A
-
Acute lymphoblastic leukemia
Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia [Volume 10, Issue 2, 2022, Pages 86-94]
-
ALL
Expression of Ten-Eleven Translocation 1 Gene in Acute Leukemia [Volume 10, Issue 4, 2022, Pages 209-218]
-
AML
Expression of Ten-Eleven Translocation 1 Gene in Acute Leukemia [Volume 10, Issue 4, 2022, Pages 209-218]
-
Androgen receptor
Prevalence of Androgen Receptors Expression in Triple Negative Breast Cancer Patients and its Correlation with Clinicopathological Criteria: Our Institutes Experience [Volume 10, Issue 4, 2022, Pages 242-250]
B
-
Bevacizumab
Bevacizumab and weekly dose-dense paclitaxel and carboplatin in recurrent epithelial ovarian carcinoma: A phase II trial [Volume 10, Issue 4, 2022, Pages 259-265]
-
Bladder cancer
Hormonal receptors expression in urinary bladder cancer [Volume 10, Issue 2, 2022, Pages 108-115]
-
Bladder cancer
Significance of HER2 expression in urinary bladder cancer: single institutional data [Volume 10, Issue 3, 2022, Pages 136-145]
-
Bladder preservation
Bladder preservation with conformal radiotherapy using a simultaneous boost with concurrent cisplatin in patients with muscle-invasive bladder cancer [Volume 10, Issue 2, 2022, Pages 129-135]
C
-
Calcium Scoring
Value of calcium scoring in addition to myocardial perfusion imaging in patients with coronary artery disease [Volume 10, Issue 3, 2022, Pages 146-151]
-
Carboplatin
Bevacizumab and weekly dose-dense paclitaxel and carboplatin in recurrent epithelial ovarian carcinoma: A phase II trial [Volume 10, Issue 4, 2022, Pages 259-265]
-
CD66c
Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia [Volume 10, Issue 2, 2022, Pages 86-94]
-
CD8
Prevalence And Prognostic Value of (TILs) Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients [Volume 10, Issue 3, 2022, Pages 191-197]
-
Chemokines
CXCL12 rs1801157 polymorphism is associated with risk and poor prognosis of non-Hodgkin´s Lymphoma [Volume 10, Issue 1, 2022, Pages 17-26]
-
Chemotherapy
Role of Radiotherapy with or without Chemotherapy in Treatment of Cancer Urinary Bladder Surgically Excised: A Retrospective Study [Volume 10, Issue 4, 2022, Pages 314-324]
-
Cisplatin
The Predictive Value of Fragile-site Associated Tumor Suppressor (FATS) Gene Expression on the Sensitivity of Cisplatin in Advanced Non-Small Cell Lung Cancer [Volume 10, Issue 2, 2022, Pages 116-120]
-
Cisplatin
Weekly versus every three weeks cisplatin as concurrent chemoradiotherapy in locally advanced head and neck cancer: single institution experience [Volume 10, Issue 2, 2022, Pages 121-128]
-
Cisplatin
Bladder preservation with conformal radiotherapy using a simultaneous boost with concurrent cisplatin in patients with muscle-invasive bladder cancer [Volume 10, Issue 2, 2022, Pages 129-135]
-
Clinical Outcome
Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study [Volume 10, Issue 1, 2022, Pages 27-33]
-
Compliance
Adherence and Discontinuation of Endocrine Therapy among Egyptian Breast Cancer Patients Receiving Adjuvant Treatment: A Cross-sectional Study [Volume 10, Issue 1, 2022, Pages 1-7]
-
Concurrent Chemotherapy
Concurrent Chemoradiation versus Radiotherapy Alone in Adjuvant Setting for High-Risk Endometrial Carcinoma [Volume 10, Issue 3, 2022, Pages 170-175]
-
Coronary Artery Disease
Value of calcium scoring in addition to myocardial perfusion imaging in patients with coronary artery disease [Volume 10, Issue 3, 2022, Pages 146-151]
-
Cortical scar
Inter-and intra-reader reliability of 99mTc- DMSA planar vs. SPECT/CT scintigraphy in the detection of renal cortical defects [Volume 10, Issue 4, 2022, Pages 198-201]
-
COVID pandemic
Efficacy and Feasibility of Long-Acting Every Three Months Goserelin for Premenopausal Breast Cancer Patients during the COVID Pandemic [Volume 10, Issue 4, 2022, Pages 234-241]
-
CXCL12
CXCL12 rs1801157 polymorphism is associated with risk and poor prognosis of non-Hodgkin´s Lymphoma [Volume 10, Issue 1, 2022, Pages 17-26]
D
-
Discontinuation
Adherence and Discontinuation of Endocrine Therapy among Egyptian Breast Cancer Patients Receiving Adjuvant Treatment: A Cross-sectional Study [Volume 10, Issue 1, 2022, Pages 1-7]
-
DNA demethylation
Expression of Ten-Eleven Translocation 1 Gene in Acute Leukemia [Volume 10, Issue 4, 2022, Pages 209-218]
E
-
Endometrial carcinoma
Concurrent Chemoradiation versus Radiotherapy Alone in Adjuvant Setting for High-Risk Endometrial Carcinoma [Volume 10, Issue 3, 2022, Pages 170-175]
-
Epstein–Barr virus
Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute [Volume 10, Issue 2, 2022, Pages 101-107]
-
Er
Hormonal receptors expression in urinary bladder cancer [Volume 10, Issue 2, 2022, Pages 108-115]
F
-
Fats
The Predictive Value of Fragile-site Associated Tumor Suppressor (FATS) Gene Expression on the Sensitivity of Cisplatin in Advanced Non-Small Cell Lung Cancer [Volume 10, Issue 2, 2022, Pages 116-120]
-
Flowcytometry
Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia [Volume 10, Issue 2, 2022, Pages 86-94]
H
-
HCV
Effect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients [Volume 10, Issue 4, 2022, Pages 219-224]
-
Hepatocellular carcinoma
Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Sorafenib versus Radiotherapy [Volume 10, Issue 1, 2022, Pages 34-43]
-
Hepatocellular carcinoma
The interaction of sphingosine1 phosphate, adiponectin, and sex Hormones with sex disparity among patients with hepatocellular carcinoma [Volume 10, Issue 2, 2022, Pages 73-85]
-
HER2 expression
Significance of HER2 expression in urinary bladder cancer: single institutional data [Volume 10, Issue 3, 2022, Pages 136-145]
-
Her-2 +ve breast cancer
Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study [Volume 10, Issue 1, 2022, Pages 27-33]
-
Hormonal Receptors
Hormonal receptors expression in urinary bladder cancer [Volume 10, Issue 2, 2022, Pages 108-115]
-
Hormonal therapy
Adherence and Discontinuation of Endocrine Therapy among Egyptian Breast Cancer Patients Receiving Adjuvant Treatment: A Cross-sectional Study [Volume 10, Issue 1, 2022, Pages 1-7]
I
-
I-131
Impact of lymphocytic thyroiditis on the outcome of papillary thyroid carcinoma treated with radioactive iodine I-131 [Volume 10, Issue 1, 2022, Pages 8-16]
-
Immunotherapy
Prevalence And Prognostic Value of (TILs) Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients [Volume 10, Issue 3, 2022, Pages 191-197]
-
IMRT
Outcomes, Toxicities, and Dosimetric Comparison of Different Hypo-fractionated Intensity Modulated Radiotherapy Techniques for Treatment of Localized Prostate Cancer [Volume 10, Issue 4, 2022, Pages 251-258]
-
Induction response
Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response [Volume 10, Issue 2, 2022, Pages 66-72]
-
Interleukin-22
Effect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients [Volume 10, Issue 4, 2022, Pages 219-224]
-
Interleukin-32α
Effect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients [Volume 10, Issue 4, 2022, Pages 219-224]
-
Interleukin-34
Effect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients [Volume 10, Issue 4, 2022, Pages 219-224]
L
-
Lapatinib
Efficacy and Safety of Lapatinib in Elderly Egyptian Patients with Her2 neu Positive Metastatic Breast Cancer [Volume 10, Issue 4, 2022, Pages 225-233]
-
Leukemia
Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response [Volume 10, Issue 2, 2022, Pages 66-72]
-
Low dose
Weekly versus every three weeks cisplatin as concurrent chemoradiotherapy in locally advanced head and neck cancer: single institution experience [Volume 10, Issue 2, 2022, Pages 121-128]
-
Lymphoma
Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute [Volume 10, Issue 2, 2022, Pages 101-107]
M
-
Malnutrition
Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response [Volume 10, Issue 2, 2022, Pages 66-72]
-
Management
Retrospective analysis of prognostic factors, management, and pattern of failure in Metastatic Prostatic Cancer in Assiut University Hospital in the last ten years [Volume 10, Issue 2, 2022, Pages 95-100]
-
Metastatic breast cancer
Prognostic value of tumor infiltrating lymphocyte in metastatic breast cancer [Volume 10, Issue 3, 2022, Pages 162-169]
-
Metastatic breast cancer
Efficacy and Safety of Lapatinib in Elderly Egyptian Patients with Her2 neu Positive Metastatic Breast Cancer [Volume 10, Issue 4, 2022, Pages 225-233]
-
Minimal residual disease
Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia [Volume 10, Issue 2, 2022, Pages 86-94]
-
Muscle invasive bladder cancer
Role of Radiotherapy with or without Chemotherapy in Treatment of Cancer Urinary Bladder Surgically Excised: A Retrospective Study [Volume 10, Issue 4, 2022, Pages 314-324]
-
Myocardial
Value of calcium scoring in addition to myocardial perfusion imaging in patients with coronary artery disease [Volume 10, Issue 3, 2022, Pages 146-151]
N
-
Nasopharyngeal carcinoma
Clinico-epidemiological Study of Locally Advanced Nasopharyngeal Carcinoma [Volume 10, Issue 2, 2022, Pages 44-55]
-
Neoplastic
Histopathological pattern of thyroidectomy specimens at South Egypt Cancer Institute: A cross sectional study [Volume 10, Issue 2, 2022, Pages 56-65]
-
NHL
CXCL12 rs1801157 polymorphism is associated with risk and poor prognosis of non-Hodgkin´s Lymphoma [Volume 10, Issue 1, 2022, Pages 17-26]
-
NHL
Effect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients [Volume 10, Issue 4, 2022, Pages 219-224]
-
NSCLC
The Predictive Value of Fragile-site Associated Tumor Suppressor (FATS) Gene Expression on the Sensitivity of Cisplatin in Advanced Non-Small Cell Lung Cancer [Volume 10, Issue 2, 2022, Pages 116-120]
O
-
Overall survival
Clinico-epidemiological Study of Locally Advanced Nasopharyngeal Carcinoma [Volume 10, Issue 2, 2022, Pages 44-55]
-
Overall survival
Prognostic value of tumor infiltrating lymphocyte in metastatic breast cancer [Volume 10, Issue 3, 2022, Pages 162-169]
-
Overall survival
Retrospective Epidemiological Study and Prognostic Factors of Renal Cell Carcinoma [Volume 10, Issue 3, 2022, Pages 176-184]
P
-
Paclitaxel
Bevacizumab and weekly dose-dense paclitaxel and carboplatin in recurrent epithelial ovarian carcinoma: A phase II trial [Volume 10, Issue 4, 2022, Pages 259-265]
-
Papillary thyroid carcinoma
Impact of lymphocytic thyroiditis on the outcome of papillary thyroid carcinoma treated with radioactive iodine I-131 [Volume 10, Issue 1, 2022, Pages 8-16]
-
PCR-RFLP
CXCL12 rs1801157 polymorphism is associated with risk and poor prognosis of non-Hodgkin´s Lymphoma [Volume 10, Issue 1, 2022, Pages 17-26]
-
Pediatric
Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response [Volume 10, Issue 2, 2022, Pages 66-72]
-
Pediatrics
Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute [Volume 10, Issue 2, 2022, Pages 101-107]
-
Perfusion Imaging
Value of calcium scoring in addition to myocardial perfusion imaging in patients with coronary artery disease [Volume 10, Issue 3, 2022, Pages 146-151]
-
Planar scintigraphy
Inter-and intra-reader reliability of 99mTc- DMSA planar vs. SPECT/CT scintigraphy in the detection of renal cortical defects [Volume 10, Issue 4, 2022, Pages 198-201]
-
Portal venous tumor thrombosis
Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Sorafenib versus Radiotherapy [Volume 10, Issue 1, 2022, Pages 34-43]
-
PR
Hormonal receptors expression in urinary bladder cancer [Volume 10, Issue 2, 2022, Pages 108-115]
-
Prognostic factors
Retrospective analysis of prognostic factors, management, and pattern of failure in Metastatic Prostatic Cancer in Assiut University Hospital in the last ten years [Volume 10, Issue 2, 2022, Pages 95-100]
-
Prognostic factors
Outcome and Prognostic Factors in Recurrent Glioblastoma Multiforme Treated with Re-Irradiation: A Retrospective Study from a Tertiary Care Hospital [Volume 10, Issue 3, 2022, Pages 152-161]
-
Prognostic factors
Retrospective Epidemiological Study and Prognostic Factors of Renal Cell Carcinoma [Volume 10, Issue 3, 2022, Pages 176-184]
R
-
Radical cystectomy
Role of Radiotherapy with or without Chemotherapy in Treatment of Cancer Urinary Bladder Surgically Excised: A Retrospective Study [Volume 10, Issue 4, 2022, Pages 314-324]
-
Radiotherapy
Concurrent Chemoradiation versus Radiotherapy Alone in Adjuvant Setting for High-Risk Endometrial Carcinoma [Volume 10, Issue 3, 2022, Pages 170-175]
-
Radiotherapy (VMAT)
Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Sorafenib versus Radiotherapy [Volume 10, Issue 1, 2022, Pages 34-43]
-
Real-Time PCR
Expression of Ten-Eleven Translocation 1 Gene in Acute Leukemia [Volume 10, Issue 4, 2022, Pages 209-218]
-
Recurrent glioblastoma
Outcome and Prognostic Factors in Recurrent Glioblastoma Multiforme Treated with Re-Irradiation: A Retrospective Study from a Tertiary Care Hospital [Volume 10, Issue 3, 2022, Pages 152-161]
-
Reirradiation
Outcome and Prognostic Factors in Recurrent Glioblastoma Multiforme Treated with Re-Irradiation: A Retrospective Study from a Tertiary Care Hospital [Volume 10, Issue 3, 2022, Pages 152-161]
-
Renal cell carcinoma
Retrospective Epidemiological Study and Prognostic Factors of Renal Cell Carcinoma [Volume 10, Issue 3, 2022, Pages 176-184]
-
Retrospective
Weekly versus every three weeks cisplatin as concurrent chemoradiotherapy in locally advanced head and neck cancer: single institution experience [Volume 10, Issue 2, 2022, Pages 121-128]
-
RRA
Impact of lymphocytic thyroiditis on the outcome of papillary thyroid carcinoma treated with radioactive iodine I-131 [Volume 10, Issue 1, 2022, Pages 8-16]
S
-
Set up verification
Adaptive MV portal imaging for head and neck cancer, a model for countries with limited resources [Volume 10, Issue 3, 2022, Pages 185-190]
-
SNP
CXCL12 rs1801157 polymorphism is associated with risk and poor prognosis of non-Hodgkin´s Lymphoma [Volume 10, Issue 1, 2022, Pages 17-26]
-
Sorafenib
Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Sorafenib versus Radiotherapy [Volume 10, Issue 1, 2022, Pages 34-43]
-
SPECT/CT
Inter-and intra-reader reliability of 99mTc- DMSA planar vs. SPECT/CT scintigraphy in the detection of renal cortical defects [Volume 10, Issue 4, 2022, Pages 198-201]
-
Survival
Outcome and Prognostic Factors in Recurrent Glioblastoma Multiforme Treated with Re-Irradiation: A Retrospective Study from a Tertiary Care Hospital [Volume 10, Issue 3, 2022, Pages 152-161]
T
-
TET1
Expression of Ten-Eleven Translocation 1 Gene in Acute Leukemia [Volume 10, Issue 4, 2022, Pages 209-218]
-
Thyroid Cancer
Surgical Outcome of Thyroid Cancer: 5 Year Experience South Egypt Cancer Institute [Volume 10, Issue 4, 2022, Pages 202-208]
-
Thyroidectomy
Surgical Outcome of Thyroid Cancer: 5 Year Experience South Egypt Cancer Institute [Volume 10, Issue 4, 2022, Pages 202-208]
-
TIL
Prevalence And Prognostic Value of (TILs) Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer Patients [Volume 10, Issue 3, 2022, Pages 191-197]
-
Tumor infiltrating lymphocytes
Prognostic value of tumor infiltrating lymphocyte in metastatic breast cancer [Volume 10, Issue 3, 2022, Pages 162-169]
W
-
WHO classification
Histopathological pattern of thyroidectomy specimens at South Egypt Cancer Institute: A cross sectional study [Volume 10, Issue 2, 2022, Pages 56-65]
Your query does not match with any item